Can-Fite BioPharma Ltd. (CANF)

AMEX: CANF · Real-Time Price · USD

1.04

-0.05 (-4.59%)

At close: May 01, 2025, 3:59 PM

1.04

-0.48%

After-hours: May 01, 2025, 07:50 PM EDT

Can-Fite BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	674K	743K	810K	853K	763K	2.03M	3.82M	844.75K	169.5K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	674K	743K	810K	853K	763K	2.03M	3.82M	844.75K	169.5K
Operating Income	-8.13M	-8.2M	-10.1M	-12.84M	-14.14M	-12.01M	-5.41M	-7.38M	-8.63M
Interest Income	291K	506K	222K	24K	44K	72K	51K	2.99M	88.91K
Pretax Income	-7.88M	-7.63M	-10.17M	-12.62M	-14.44M	-12.63M	-6.57M	-4.95M	-6.99M
Net Income	-7.88M	-7.63M	-10.17M	-12.62M	-14.44M	-12.63M	-6.57M	-6.34M	-8.26M
Selling & General & Admin	3.05M	2.96M	3.14M	3.85M	2.95M	3.06M	3.16M	2.95M	2.7M
Research & Development	5.76M	5.98M	7.76M	9.85M	11.95M	10.98M	6.08M	5.27M	6.08M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	8.8M	8.94M	10.91M	13.7M	14.9M	14.04M	9.23M	8.22M	8.8M
Interest Expense	14K	14K	63K	22K	363K	427K	1.2M	1.1M	27.3K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	31.07K	n/a
Cost & Expenses	8.8M	8.94M	10.91M	13.7M	14.9M	14.04M	9.23M	8.22M	8.8M
Income Tax Expense	n/a	n/a	63K	-20K	363K	427K	4K	29.92K	29.12K
Shares Outstanding (Basic)	24.18K	18.06K	10.88K	6.12K	4.55K	1.15K	518.00	433.00	369.00
Shares Outstanding (Diluted)	24.18K	18.06K	10.88K	7.37K	4.78K	1.15K	518.00	433.00	369.00
EPS (Basic)	-32.59K	-0.42	-0.93	-2.07	-3.18	-11.01	-12.66	-14.61	-22.35
EPS (Diluted)	-32.59K	-0.42	-0.93	-1.71	-3.03	-11.01	-12.66	-14.61	-22.35
EBITDA	-8.12M	-8.18M	-10.08M	-12.83M	-14.13M	-11.99M	-6.54M	-6.36M	-8.68M
EBIT	-8.13M	-8.2M	-10.1M	-12.84M	-14.14M	-12.01M	-6.14M	-6.4M	-6.98M
Depreciation & Amortization	7K	15K	14K	14K	12K	14K	14K	19K	18.5K